{"id":"W2049143320","doi":"10.1111/j.1365-2036.2006.02748.x","title":"Treating chronic hepatitis C with pegylated interferon alfa‐2a (40 KD) and ribavirin in clinical practice","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); Toronto Western Hospital; Toronto General Hospital; University Health Network; Royal Victoria Hospital; Vancouver Hospital and Health Sciences Centre; BC Centre for Disease Control; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"F. Hoffmann-La Roche","keywords":"Ribavirin; Medicine; Internal medicine; Pegylated interferon; Adverse effect; Gastroenterology; Clinical trial; Randomized controlled trial; Hepatitis C; Cirrhosis; Hepatitis C virus; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000741854,0.0002821081,0.0004852556,0.000194662,0.0001076743,0.00002693255,0.0001386515,0.0001885397,0.0005592094],"category_scores_gemma":[0.000002786426,0.0002481988,0.00006213442,0.000310445,0.0004165199,0.0002508486,0.0001113847,0.0009014867,0.00005432337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004602739,"about_ca_system_score_gemma":0.0002896628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004315735,"about_ca_topic_score_gemma":0.00243553,"domain_scores_codex":[0.9971071,0.000694374,0.0007363989,0.0005217792,0.0003379973,0.0006022748],"domain_scores_gemma":[0.998606,0.0006977954,0.0001724488,0.0002409067,0.0001196652,0.000163189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004388593,0.001701624,0.8926084,0.00007301893,0.004245984,0.001684139,0.0003775678,0.00004451997,0.04072614,0.00002285326,0.001018948,0.05310823],"study_design_scores_gemma":[0.04551544,0.02219795,0.6333429,0.0004688824,0.01527789,0.001135287,0.0004885177,0.02135869,0.05737646,0.0001125526,0.2013748,0.001350665],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853423,0.0031884,0.00004101405,0.007713516,0.0002210403,0.0009220876,0.00002099592,0.00007274032,0.002477955],"genre_scores_gemma":[0.9805589,0.005918149,0.001394316,0.01109943,0.0004063784,0.00007523791,0.0001210841,0.00006320537,0.0003632722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2592655,"threshold_uncertainty_score":0.999997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03742171039494784,"score_gpt":0.410042578304414,"score_spread":0.3726208679094661,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}